← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 6, 2018Last known activity
Nov 11, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT04637152Lead sponsorPhase 2Nov 11, 2020
- NCT04637152Reponsible party - principal investigatorPhase 2Nov 11, 2020
- NCT03566303Lead sponsorPhase 2/Phase 3Jun 6, 2018
Details
- Last known activity
- Nov 11, 2020